German
|
English
|
French
Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "M05BX" (32)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Aluminium Chlorohydrate (M05BX02) 1 products
WHO-DDD
L
IP
CI
Phosphonorm
100 Capsule(s)
31.97
51.20
10 %
Capsules: Aluminii Chloridum/hydroxidum Hydricum (9:8:19:23) 300 mg
Salmon Pharma GmbH
B / SL
FB
G
Denosumab (M05BX04) 23 products
WHO-DDD
DrugBank.ca
L
IP
XGEVA 120 mg
Durchstechflasche(n)
229.39
269.30
10 %
Injection solution: Denosumabum 120mg / 1.7ml
Amgen Switzerland AG
A / SL / SO
FB
G
L
IP
CI
XGEVA 120 mg/1 ml
229.39
269.30
10 %
Injection solution in prefilled syringe: Denosumabum 120 mg
Amgen Switzerland AG
A / SL / SO
FB
G
L
IP
CI
Prolia
syringe(s)
191.86
224.00
10 %
Injektionslösung in Fertigspritze mit Nadelschutz: Denosumabum 60 mg/ml
Amgen Switzerland AG
B / SL / SO
FB
G
IP
Denosumab-Mepha osteo 60
mg/ml
10 %
Mepha Pharma AG
B / SL / SG
FB
G
IP
Denosumab-Teva onco 120 mg / 1.7 ml
10 %
Teva Pharma AG
A / SL / SG
FB
G
L
IP
Jubereq 120 mg/1.7 ml
172.04
210.45
10 %
Injection solution: Denosumabum 120 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
Osenvelt 120 mg/1.7 ml (70
mg/ml)
172.04
210.45
10 %
Injection solution: Denosumabum 120mg / 1.7ml
iQone Healthcare
Switzerland SA
A / SL / SG
FB
G
L
IP
Wyost 120 mg/ 1.7 ml
172.04
210.45
10 %
Injection solution: Denosumabum 120 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Xbryk 120 mg/1.7 ml
172.04
210.45
10 %
Injection solution: Denosumabum 120mg / 1.7ml
Samsung Bioepis CH
GmbH
A / SL / SG
FB
G
L
IP
CI
Evfraxy 60 mg/ml
174.42
206.10
10 %
Injection solution in prefilled syringe: Denosumabum 60 mg/ml
Medius AG
B / SL / SG
FB
G
L
IP
CI
Jubbonti 60 mg/ml
174.42
206.10
10 %
Injection solution in prefilled syringe: Denosumabum 60 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Obodence
153.90
185.05
10 %
Injection solution in prefilled syringe: Denosumabum 60 mg/ml
Samsung Bioepis CH
GmbH
B / SL / SG
FB
G
L
IP
CI
Osvyrti 60 mg/1.0 ml
174.42
206.10
10 %
Injection solution in prefilled syringe: Denosumabum 60 mg
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
CI
Stoboclo 60 mg
174.42
206.10
10 %
solution injectable en seringue préremplie: Denosumabum 60 mg/ml
iQone Healthcare
Switzerland SA
B / SL / SG
FB
G
IP
CI
Denosumab-Mepha osteo,
Injektionslösung in einer
Fertigspritze
174.42
206.10
10 %
Mepha Pharma AG
B / SG
FB
G
IP
Denosumab-Teva onco 120 mg / 1.7 ml
172.04
210.45
10 %
Injection solution: Denosumabum 120mg / 1.7ml
Teva Pharma AG
A / SG
FB
G
IP
Denosumab-Teva onco,
Injektionslösung
k.A.
Teva Pharma AG
FB
G
Vevzuo 120 mg/1.7 ml (70
mg/ml)
k.A.
Injection solution: Denosumabum 120mg / 1.7ml
Medius AG
A
FB
G
IP
Denosumab-Teva onco 120 mg / 1.7 ml
3
k.A.
Teva Pharma AG
A
FB
G
IP
XGEVA 120 mg
4 Durchstechflasche(n)
k.A.
Injection solution: Denosumabum 120mg / 1.7ml
Amgen Switzerland AG
A
FB
G
Junod 60 mg/ml
k.A.
Injection solution in prefilled syringe: Denosumabum 60 mg
Gedeon Richter
(Schweiz) AG
B
FB
G
Denosumab Zentiva 60 mg
k.A.
Injektionslösung (s.c.): Denosumabum 60 mg
Helvepharm AG
B
FB
G
Prolia 60 mg / ml
k.A.
Injektionslösung in einer Fertigspritze mit Nadelschutz: Denosumabum 60 mg/ml
EurimPharm Swiss AG
B
FB
G
Burosumab (M05BX05) 3 products
WHO-DDD
IP
Crysvita 10 mg/1 ml
k.A.
Injection solution: Burosumabum 10 mg/ml
Kyowa Kirin Sàrl
B
FB
G
IP
Crysvita 20 mg/1 ml
k.A.
Injection solution: Burosumabum 20 mg/ml
Kyowa Kirin Sàrl
B
FB
G
IP
Crysvita 30 mg/1 ml
k.A.
Injection solution: Burosumabum 30 mg/ml
Kyowa Kirin Sàrl
B
FB
G
Romosozumab (M05BX06) 1 products
WHO-DDD
L
IP
CI
Evenity 105 mg/1.17 ml
2
439.49
494.40
10 %
Injection solution in prefilled syringe: Romosozumabum 105mg / 1.17ml
UCB-Pharma SA
B / SL
FB
G
Vosoritide (M05BX07) 3 products
WHO-DDD
IP
CI
Voxzogo 0.4 mg
10
k.A.
Lyophilisate and solvent: Vosoritidum
DRAC AG
A
FB
G
IP
CI
Voxzogo 0.56 mg
10
k.A.
Lyophilisate and solvent: Vosoritidum
DRAC AG
A
FB
G
IP
CI
Voxzogo 1.2 mg
10
k.A.
Lyophilisate and solvent: Vosoritidum 1.2 mg
DRAC AG
A
FB
G
Sonstige die Knochenmineralisation beeinflussende Pharmaka (Diverse) (M05BX99) 1 products
WHO-DDD
DrugBank.ca
CI
A
Weleda Aufbaukalk 1+2
k.A.
Pulver zum Einnehmen: 2 Active Agents
Pulver zum Einnehmen: 3 Active Agents
Weleda AG
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
